eClinical Solutions Market (By Product: Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems; By Delivery Mode: Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions; By Clinical Trial Phase: Phase I Clinical Trials, Phase II Clinical Trials; By End-Use: Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of eClinical Solutions
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. eClinical Solutions Market By Product
     1.2.2.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Product (2015-2026)
     1.2.2.2. Global eClinical Solutions Market Revenue Share By Product in 2018
     1.2.2.3. Electronic Data Capture and Clinical Data Management Systems
     1.2.2.4. Clinical Trial Management Systems
     1.2.2.5. Clinical Analytics Platforms
     1.2.2.6. Randomization and Trial Supply Management
     1.2.2.7. Clinical Data Integration Platforms
     1.2.2.8. Electronic Clinical Outcome Assessment Solutions
     1.2.2.9. Safety Solutions
     1.2.2.10. Electronic Trial Master File Systems
     1.2.2.11. Regulatory Information Management Solutions
     1.2.2.12. Others
   1.2.3. eClinical Solutions Market By Delivery Mode
     1.2.3.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Delivery Mode (2015-2026)
     1.2.3.2. Web-Hosted (On-Demand) Solutions
     1.2.3.3. Licensed Enterprise (On-Premise) Solutions
     1.2.3.4. Cloud-Based (SaaS) Solutions
   1.2.4. eClinical Solutions Market By Clinical Trial Phase
     1.2.4.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By Clinical Trial Phase (2015-2026)
     1.2.4.2. Phase I Clinical Trials
     1.2.4.3. Phase II Clinical Trials
     1.2.4.4. Phase III Clinical Trials
     1.2.4.5. Phase IV Clinical Trials
   1.2.5. eClinical Solutions Market By End-use
     1.2.5.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison By End-user (2015-2026)
     1.2.5.2. Pharmaceutical and Biopharmaceutical Companies
     1.2.5.3. Contract Research Organizations
     1.2.5.4. Consulting Service Companies
     1.2.5.5. Medical Device Manufacturers
     1.2.5.6. Hospitals
     1.2.5.7. Academic Research Institutes
   1.2.6. eClinical Solutions Market By Geography
     1.2.6.1. Global eClinical Solutions Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.6.2. North America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
     1.2.6.3. Europe eClinical Solutions Market Revenue and Growth Rate(2015-2026)
     1.2.6.4. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate(2015-2026)
     1.2.6.5. Latin America eClinical Solutions Market Revenue and Growth Rate(2015-2026)
     1.2.6.6. Middle East and Africa (MEA) eClinical Solutions Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global eClinical Solutions Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global eClinical Solutions Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global eClinical Solutions Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global eClinical Solutions Major Manufacturers in 2018

CHAPTER 4. ECLINICAL SOLUTIONS MARKET BY PRODUCT
4.1. Global eClinical Solutions Revenue By Product
4.2. Electronic Data Capture and Clinical Data Management Systems
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Clinical Trial Management Systems
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Clinical Analytics Platforms
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Randomization and Trial Supply Management
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Clinical Data Integration Platforms
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Electronic Clinical Outcome Assessment Solutions
   4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Safety Solutions
   4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Electronic Trial Master File Systems
   4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Regulatory Information Management Solutions
   4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Others
   4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE
5.1. Global eClinical Solutions Revenue By Delivery Mode
5.2. Web-Hosted (On-Demand) Solutions
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Licensed Enterprise (On-Premise) Solutions
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cloud-Based (SaaS) Solutions
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE
6.1. Global eClinical Solutions Revenue By Clinical Trial Phase
6.2. Phase I Clinical Trials
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Phase II Clinical Trials
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Phase III Clinical Trials
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Phase IV Clinical Trials
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. ECLINICAL SOLUTIONS MARKET By End-use
7.1. Global eClinical Solutions Revenue By End-use
7.2. Pharmaceutical and Biopharmaceutical Companies
   7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Contract Research Organizations
   7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Consulting Service Companies
   7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Medical Device Manufacturers
   7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Hospitals
   7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Academic Research Institutes
   7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. NORTH AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
8.1. North America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. U.S.
   8.3.1. U.S. eClinical Solutions Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   8.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Canada
   8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   8.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 9. EUROPE ECLINICAL SOLUTIONS MARKET BY COUNTRY
9.1. Europe eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. UK
   9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   9.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Germany
   9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   9.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. France
   9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   9.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Spain
   9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   9.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. Rest of Europe
   9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   9.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET BY COUNTRY
10.1. Asia-Pacific eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. China
   10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Japan
   10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. India
   10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.6. Australia
   10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.6.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.6.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.6.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.7. South Korea
   10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.7.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.7.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.7.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
   10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.8.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   10.8.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   10.8.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 11. LATIN AMERICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
11.1. Latin America eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Brazil
   11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   11.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. Mexico
   11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   11.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Latin America
   11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   11.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA ECLINICAL SOLUTIONS MARKET BY COUNTRY
12.1. Middle East & Africa eClinical Solutions Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East & Africa eClinical Solutions Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. GCC
   12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   12.3.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   12.3.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   12.3.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. South Africa
   12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   12.4.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   12.4.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   12.4.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Middle East & Africa
   12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   12.5.2. Market Revenue and Forecast By Delivery Mode, 2015 - 2026 ($Million)
   12.5.3. Market Revenue and Forecast By Clinical Trial Phase, 2015 - 2026 ($Million)
   12.5.4. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Oracle Corporation
   13.1.1. Company Snapshot
   13.1.2. Overview
   13.1.3. Financial Overview
   13.1.4. Type Portfolio
   13.1.5. Key Developments
   13.1.6. Strategies
13.2. Medidata Solutions, Inc.
   13.2.1. Company Snapshot
   13.2.2. Overview
   13.2.3. Financial Overview
   13.2.4. Type Portfolio
   13.2.5. Key Developments
   13.2.6. Strategies
13.3. Parexel International Corporation
   13.3.1. Company Snapshot
   13.3.2. Overview
   13.3.3. Financial Overview
   13.3.4. Type Portfolio
   13.3.5. Key Developments
   13.3.6. Strategies
13.4. Bioclinica, Inc. (A Subsidiary of Cinven)
   13.4.1. Company Snapshot
   13.4.2. Overview
   13.4.3. Financial Overview
   13.4.4. Type Portfolio
   13.4.5. Key Developments
   13.4.6. Strategies
13.5. Datatrak International, Inc.
   13.5.1. Company Snapshot
   13.5.2. Overview
   13.5.3. Financial Overview
   13.5.4. Type Portfolio
   13.5.5. Key Developments
   13.5.6. Strategies
13.6. CRF Health
   13.6.1. Company Snapshot
   13.6.2. Overview
   13.6.3. Financial Overview
   13.6.4. Type Portfolio
   13.6.5. Key Developments
   13.6.6. Strategies
13.7. ERT Clinical
   13.7.1. Company Snapshot
   13.7.2. Overview
   13.7.3. Financial Overview
   13.7.4. Type Portfolio
   13.7.5. Key Developments
   13.7.6. Strategies
13.8. Merge Healthcare Incorporated
   13.8.1. Company Snapshot
   13.8.2. Overview
   13.8.3. Financial Overview
   13.8.4. Type Portfolio
   13.8.5. Key Developments
   13.8.6. Strategies
13.9. Omnicomm Systems, Inc.
   13.9.1. Company Snapshot
   13.9.2. Overview
   13.9.3. Financial Overview
   13.9.4. Type Portfolio
   13.9.5. Key Developments
   13.9.6. Strategies
13.10. Maxisit Inc.
   13.10.1. Company Snapshot
   13.10.2. Overview
   13.10.3. Financial Overview
   13.10.4. Type Portfolio
   13.10.5. Key Developments
   13.10.6. Strategies
13.11. Bio-Optronics, Inc.
   13.11.1. Company Snapshot
   13.11.2. Overview
   13.11.3. Financial Overview
   13.11.4. Type Portfolio
   13.11.5. Key Developments
   13.11.6. Strategies
13.12. Others
   13.12.1. Company Snapshot
   13.12.2. Overview
   13.12.3. Financial Overview
   13.12.4. Type Portfolio
   13.12.5. Key Developments
   13.12.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
   14.1.1. Initial Data Search
   14.1.2. Secondary Research
   14.1.3. Primary Research
14.2. Assumptions and Scope


Cart Summary